Literature DB >> 10640286

Characterization of the transport properties of organic anion transporting polypeptide 1 (oatp1) and Na(+)/taurocholate cotransporting polypeptide (Ntcp): comparative studies on the inhibitory effect of their possible substrates in hepatocytes and cDNA-transfected COS-7 cells.

H Kouzuki1, H Suzuki, B Stieger, P J Meier, Y Sugiyama.   

Abstract

In the present study, we compared the inhibitory effects of organic anions (including bile acids) on the uptake of taurocholate (TC) and estradiol 17beta-D-glucuronide (E(2)17betaG), typical substrates for sodium taurocholate cotransporting polypeptide (Ntcp) and organic anion transporting polypeptide (oatp1), respectively, using primary cultured rat hepatocytes and Ntcp- or oatp1-transfected COS-7 cells. The Na(+)-dependent uptake of TC was inhibited by nine bile acids and five nonbile acid organic anions in a concentration-dependent manner, and their inhibitory effects were similar in both primary cultured rat hepatocytes and Ntcp-transfected COS-7 cells. BQ-123 (1 microM) and indomethacin (10 microM), both of which exhibit no Ntcp-mediated transport, significantly inhibited the Na(+)-dependent uptake of TC mediated by Ntcp. In addition, the Na(+)-independent uptake of E(2)17betaG was inhibited by 15 organic anions in a concentration-dependent manner, and their inhibitory effects were similar between primary cultured rat hepatocytes and oatp1-transfected COS-7 cells. BQ-123 (1 microM), pravastatin (1 microM), and indomethacin (10 microM), all of which do not undergo oatp1-mediated transport, significantly inhibited the Na(+)-independent uptake of E(2)17betaG mediated by oatp1. These results are consistent with the hypothesis that the hepatic uptake of TC and E(2)17betaG is predominantly mediated by Ntcp and oatp1, respectively. In addition, it was clearly demonstrated that we cannot refer to the substrate specificity of transporters based on inhibition studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640286

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity.

Authors:  Brandon Swift; Nathan D Pfeifer; Kim L R Brouwer
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

2.  Hepatic disposition of fexofenadine: influence of the transport inhibitors erythromycin and dibromosulphothalein.

Authors:  R W Milne; L A Larsen; K L Jørgensen; J Bastlund; G R Stretch; A M Evans
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

3.  Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport.

Authors:  Yoshihisa Shitara; Daisuke Sugiyama; Hiroyuki Kusuhara; Yukio Kato; Takaaki Abe; Peter J Meier; Tomoo Itoh; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

4.  Pharmacokinetic study of the hepatobiliary transport of indomethacin.

Authors:  H Kouzuki; H Suzuki; Y Sugiyama
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

Review 5.  Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters.

Authors:  M Sawkat Anwer; Bruno Stieger
Journal:  Pflugers Arch       Date:  2013-10-03       Impact factor: 3.657

6.  Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups.

Authors:  David T Szabo; Vicki M Richardson; David G Ross; Janet J Diliberto; Prasada R S Kodavanti; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2008-10-31       Impact factor: 4.849

Review 7.  Cholestasis.

Authors:  R Oude Elferink
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 8.  Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.

Authors:  Yohannes Hagos; Natascha A Wolff
Journal:  Toxins (Basel)       Date:  2010-08-09       Impact factor: 4.546

9.  Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids.

Authors:  Michael Kirstgen; Kira Alessandra Alicia Theresa Lowjaga; Simon Franz Müller; Nora Goldmann; Felix Lehmann; Sami Alakurtti; Jari Yli-Kauhaluoma; Dieter Glebe; Joachim Geyer
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

10.  Comparison of human hepatoma HepaRG cells with human and rat hepatocytes in uptake transport assays in order to predict a risk of drug induced hepatotoxicity.

Authors:  Monika Szabo; Zsuzsa Veres; Zsolt Baranyai; Ferenc Jakab; Katalin Jemnitz
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.